Difference between revisions of "Small cell carcinoma of the prostate gland"

From Libre Pathology
Jump to navigation Jump to search
 
(2 intermediate revisions by the same user not shown)
Line 33: Line 33:
'''Small cell carcinoma of the prostate gland''' is a rare type of [[prostate cancer]] with an aggressive course.
'''Small cell carcinoma of the prostate gland''' is a rare type of [[prostate cancer]] with an aggressive course.


''Neuroendocrine carcinoma of the prostate'' redirects to here.<ref name=pmid19092321>{{Cite journal  | last1 = Stein | first1 = ME. | last2 = Bernstein | first2 = Z. | last3 = Abacioglu | first3 = U. | last4 = Sengoz | first4 = M. | last5 = Miller | first5 = RC. | last6 = Meirovitz | first6 = A. | last7 = Zouhair | first7 = A. | last8 = Freixa | first8 = SV. | last9 = Poortmans | first9 = PH. | title = Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network. | journal = Am J Med Sci | volume = 336 | issue = 6 | pages = 478-88 | month = Dec | year = 2008 | doi = 10.1097/MAJ.0b013e3181731e58 | PMID = 19092321 }}</ref><ref>{{Cite journal  | last1 = Alanee | first1 = S. | last2 = Moore | first2 = A. | last3 = Nutt | first3 = M. | last4 = Holland | first4 = B. | last5 = Dynda | first5 = D. | last6 = El-Zawahry | first6 = A. | last7 = McVary | first7 = KT. | title = Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer. | journal = Anticancer Res | volume = 35 | issue = 7 | pages = 4145-50 | month = Jul | year = 2015 | doi =  | PMID = 26124369 }}</ref>
The more general topic of ''[[prostate cancer with neuroendocrine differentiation]]'' is dealt with in a separate article.


==General==
==General==
Line 60: Line 60:
*[[Small cell carcinoma of the urinary bladder]].
*[[Small cell carcinoma of the urinary bladder]].
*[[Lymphoma]], large cell.
*[[Lymphoma]], large cell.
*[[Prostate carcinoma with amphicrine features]] - also have [[AR]] staining.<ref name=pmid28756619>{{Cite journal  | last1 = Prendeville | first1 = S. | last2 = Al-Bozom | first2 = I. | last3 = Compérat | first3 = E. | last4 = Sweet | first4 = J. | last5 = Evans | first5 = AJ. | last6 = Ben-Gashir | first6 = M. | last7 = Mete | first7 = O. | last8 = van der Kwast | first8 = TH. | last9 = Downes | first9 = MR. | title = Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? | journal = Histopathology | volume = 71 | issue = 6 | pages = 926-933 | month = Dec | year = 2017 | doi = 10.1111/his.13330 | PMID = 28756619 }}</ref>
*Other [[small round cell tumours]].
*Other [[small round cell tumours]].


Line 88: Line 89:
*[[Prostate cancer]].
*[[Prostate cancer]].
*[[Small cell carcinoma]].
*[[Small cell carcinoma]].
*[[Paneth cell-like change of the prostate gland]].


==References==
==References==

Latest revision as of 16:33, 19 March 2018

Small cell carcinoma of the prostate gland
Diagnosis in short

Small cell carcinoma of the prostate. H&E stain.

LM small cells with nuclear moulding, stippled chromatin and high NC ratio, +/-high-grade acinar adenocarcinoma (common)
LM DDx small cell carcinoma of the urinary bladder, metastatic small cell carcinoma, poorly differentiated prostate carcinoma
IHC chromogranin A +ve, PSA -ve/+ve
Grossing notes prostate biopsy, prostate chips, radical prostatectomy
Staging prostate cancer staging
Site prostate gland - see prostate cancer

Prevalence rare
Blood work PSA low (in relation to conventional cancer)
Prognosis poor
Clin. DDx other types of prostate cancer, metastatic cancer
Treatment chemotherapy

Small cell carcinoma of the prostate gland is a rare type of prostate cancer with an aggressive course.

The more general topic of prostate cancer with neuroendocrine differentiation is dealt with in a separate article.

General

Clinical:

  • PSA often low in comparison to conventional prostate cancer.[1]

Microscopic

Features:

  • Small cells with:
    • Nuclear moulding.
    • Stippled chromatin.
    • High NC ratio.
  • +/-High-grade acinar adenocarcinoma, i.e. conventional prostate carcinoma, seen in ~50% of cases.[1]

Notes:

DDx:

Images

Case

www

IHC

Features:[1]

  • PSA weak +ve/-ve.
  • Chromogranin +ve.

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 Furtado, P.; Lima, MV.; Nogueira, C.; Franco, M.; Tavora, F. (2011). "Review of small cell carcinomas of the prostate.". Prostate Cancer 2011: 543272. doi:10.1155/2011/543272. PMID 22110988.
  2. Epstein, JI.; Allsbrook, WC.; Amin, MB.; Egevad, LL. (Sep 2005). "The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.". Am J Surg Pathol 29 (9): 1228-42. PMID 16096414.
  3. Prendeville, S.; Al-Bozom, I.; Compérat, E.; Sweet, J.; Evans, AJ.; Ben-Gashir, M.; Mete, O.; van der Kwast, TH. et al. (Dec 2017). "Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?". Histopathology 71 (6): 926-933. doi:10.1111/his.13330. PMID 28756619.